SEC Form 4 · accession 0001140361-15-042240
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Demane
Officer — Chief Executive Officer · Director
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 8:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 16, 2015 | S | 26,667 | $50.5189 | D | 573,941 | D | |
| Common StockF2 | Nov 16, 2015 | S | 6,667 | $50.5189 | D | 37,587 | I | See foonote |
| Common StockF3 | Nov 16, 2015 | S | 6,667 | $50.5189 | D | 111,199 | I | See foonote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- F2Shares held by The Michael F. DeMane 2013 Retained Annuity Trust.
- F3Shares held by The Michael F. DeMane 2012 Retained Annuity Trust u/a/d July 26, 2012.